clopidogrel has been researched along with Brain Hemorrhage, Cerebral in 64 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (1.56) | 18.2507 |
2000's | 14 (21.88) | 29.6817 |
2010's | 43 (67.19) | 24.3611 |
2020's | 6 (9.38) | 2.80 |
Authors | Studies |
---|---|
Cheng, Y; Ge, W; Huang, L; Shao, P; Shao, T; Xu, H; Xu, Y; Yang, D; Zhang, M | 1 |
Kwaan, H; Lindholm, PF; Luo, Y; Metcalf-Doetsch, W; Naidech, AM; Shin, HJ; Tang, M | 1 |
Chen, HS; Cui, Y; Dong, YL; Guo, LY; Han, J; Huang, SM; Jiang, CH; Li, J; Li, JY; Li, YS; Li, Z; Lin, YZ; Lu, J; Ma, GB; Nguyen, TN; Piao, XY; Shen, LY; Wan, LS; Wang, DL; Wang, EQ; Wang, J; Wang, LX; Wang, RX; Wang, WZ; Xia, L; Yang, KH; Yang, QC; Zhang, H; Zhang, L; Zhou, ZH | 1 |
Chan, L; Chen, YC; Hsu, CY; Hu, CJ; Lin, CL; Muo, CH; Vidyanti, AN; Wu, D | 1 |
Arias, F; Benavente, L; Cadenas, M; Calleja, S; Chaviano, J; González, M; Jimenez, JM; Larrosa, D; Lopez-Cancio, E; Morales, E; Murias, E; Peña, J; Rico, M; Riesco, N; Saiz, A; Vega, P | 1 |
Al-Shahi Salman, R; Christensen, H; Gaist, D; García Rodríguez, LA; Hald, SM; Hallas, J; Hellfritzsch, M; Möller, S; Pottegård, A; Sharma, M | 1 |
Hoshino, H; Houkin, K; Ishida, N; Isobe, M; Kimura, K; Matsumoto, M; Minematsu, K; Naritomi, H; Okada, Y; Omae, K; Origasa, H; Sakai, N; Tanaka, K; Terayama, Y; Tomimoto, H; Tominaga, T; Toyoda, K; Uchiyama, S; Yamaguchi, K; Yamaguchi, T; Yasuda, S | 1 |
Anderson, DC; Bazan, C; Benavente, OR; Catanese, L; Hart, RG; Kase, CS; Marti-Fabregas, J; McClure, LA; Pearce, LA; Sharma, M; Shoamanesh, A | 1 |
Bonetti, B; Bovi, P; Cappellari, M; Forlivesi, S; Toni, D; Turcato, G; Zivelonghi, C | 1 |
Christiansen, CF; Grove, EL; Henderson, VW; Horváth-Puhó, E; Schmidt, M; Sørensen, HT; Würtz, M | 1 |
Ahmed, T; Senzel, L; Spitzer, ED | 1 |
Chiang, CH; Huang, WC; Hung, CC; Kuo, FY; Liang, HL; Lin, KC; Liu, CP; Mar, GY; Tang, PL; Wang, MT; Yang, JS | 1 |
Ban, C; Ge, L; Liang, J; Ouyang, X; Wu, H; Wu, Q; Yu, H | 1 |
Benavente, OR; Bouasquevisque, DS; Shoamanesh, A | 1 |
Beynon, C; Sakowitz, OW; Unterberg, AW | 1 |
Akoudad, S; Darweesh, SK; Hofman, A; Ikram, MA; Leening, MJ; Loth, DW; Stricker, BH; Vernooij, MW | 1 |
Feng, XY; Liu, JR; Shen, XL; Su, JJ; Zhang, M; Zhao, R | 1 |
Crandall, BM; Delgado Almandoz, JE; Fease, JL; Kadkhodayan, Y; Scholz, JM; Tubman, DE | 1 |
Arrich, J; Gouya, G; Gurbel, PA; Huber, K; Pirker-Kees, A; Siller-Matula, JM; Verheugt, FW; Wolzt, M | 1 |
Archeval-Lao, J; Cai, C; Elliott, A; Grotta, JC; Hassler, A; Kawano-Castillo, J; McDonald, M; Parker, SA; Pivalizza, E; Rahbar, MH; Tremont, C; Ward, E; Wetzel, J | 1 |
Chalouhi, N; Gonzalez, LF; Jabbour, PM; Rosenwasser, RH; Starke, RM; Tjoumakaris, SI; Zanaty, M | 1 |
Chen, C; Hu, Z; Yang, L; Zheng, H | 1 |
Alvarez-Contreras, L; Jørgensen, E; Kelbaek, H; Kocka, V; Martin-Yuste, V; Sabaté, M; Saunamäki, K | 1 |
Blann, AD; Larsen, TB; Lip, GY; Rasmussen, LH; Skjøth, F | 1 |
Bruder, M; El-Fiki, A; Güresir, E; Konczalla, J; Lescher, S; Schuss, P; Seifert, V; Vatter, H | 1 |
Kilbourn, KJ; Killory, BD; Ollenschleger, M | 1 |
Alaraj, A; Aletich, V; Tesoro, E; Wong, P | 1 |
Wang, P; Wang, Y; Wang, Z; Xin, H; Xu, C | 1 |
Carlson, N; Christiansen, CB; Gerds, TA; Gislason, G; Jørgensen, ME; Kristensen, SL; Numé, AK; Olesen, JB; Pallisgaard, J; Torp-Pedersen, C | 1 |
Ahn, SH; Han, SW; Kim, YJ; Kim, YN; Lee, KY; Oh, SH; Seo, WK; Yu, S | 1 |
Fahed, E; Ghauche, J; Maarrawi, J; Menassa-Moussa, L; Moussa, R; Nohra, G; Okais, N; Rahme, R; Rizk, T; Samaha, E | 1 |
García Rodríguez, LA; González-Pérez, A; Himmelmann, A; Johansson, S; Sáez, ME | 1 |
Johnston, SC; Li, H; Liu, L; Meng, X; Pan, Y; Wang, C; Wang, D; Wang, Y; Wu, Y; Zhao, X; Zhou, Y | 1 |
Bykov, K; Choudhry, NK; Dong, YH; Donneyong, MM; Gagne, JJ; Schneeweiss, S | 1 |
Cobb, MIH; Fernando Gonzalez, L; Hauck, EF; Smith, TP; Zomorodi, AR | 1 |
Selim, M | 1 |
Alberts, MJ; Bassin, SL; Batjer, HH; Bendok, BR; Bernstein, RA; Bleck, TP; Levasseur, K; Naidech, AM | 1 |
Alberts, MJ; Bassin, SL; Batjer, HH; Bernstein, RA; Bleck, TP; Lindholm, PF; Naidech, AM | 1 |
Broekman, MJ; Fung, CY; Mahaut-Smith, MP; Marcus, AJ | 1 |
Dzialowski, I; Gahn, G; Hermann, A; Koch, R | 1 |
Alberts, MJ; Batjer, HH; Bendok, BR; Bernstein, RA; Bleck, TP; Garg, RK; Naidech, AM | 1 |
Goto, S; Toda, E | 1 |
Ahmed, N; Diedler, J; Ford, GA; Lees, KR; Luijckx, GJ; Overgaard, K; Ringleb, P; Soinne, L; Sykora, M; Uyttenboogaart, M; Wahlgren, N | 1 |
Connolly, ES; DeRosa, PA; Ducruet, AF; Grobelny, BT; Gutbrod, S; Hickman, ZL; Khandji, J; Landes, E; Lei, S; Zacharia, BE | 1 |
Reinhart, WH | 1 |
Chai, WN; He, ZH; Sun, XC; Wu, HT; Zhang, XD; Zhu, J | 1 |
Foerch, C; Lauer, A; Lo, EH; Schlunk, F; Steinmetz, H; Van Cott, EM | 1 |
Kamal, AK; Khan, M | 1 |
Barroeta-Espar, I; Delgado-Mederos, R; Martí-Fàbregas, J; Mateo, J; Sáinz Pelayo, MP; Vidal-Jordana, A | 1 |
Mascarenhas, L | 1 |
Ahmed, N; Egido, JA; Ford, GA; Lees, KR; Mazya, M; Mikulik, R; Toni, D; Wahlgren, N | 1 |
Abrigo, J; Ahuja, AT; Leung, TW; Ng, N; Siu, DY; Soo, YO; Wong, LK; Yu, S | 1 |
Bakdash, S; Bhatt, DL; Depta, JP; Fowler, J; Katzan, I; Kottke-Marchant, K; Novak, E | 1 |
Benavente, OR; Hart, RG; Palacio, S; Pearce, LA | 1 |
Comin, J; Kallmes, DF | 1 |
Churilov, L; Dowling, R; Goh, C; Mitchell, P; Yan, B | 1 |
Hart, RG; Pearce, LA; Tonarelli, SB | 1 |
Berthold, HK; Müller-Oerlinghausen, B; Tiaden, JD; Wenzel, E | 1 |
Rabinstein, AA | 1 |
Buchan, AM; Demchuk, AM; Eliasziw, M; Hill, MD; Kennedy, J; Ryckborst, KJ | 1 |
Connolly, SJ; De Caterina, R; Flaker, G; Hart, RG; Healey, JS; Hohnloser, SH; Pfeffer, MA; Pogue, J; Yusuf, S | 1 |
Algra, A; Koudstaal, PJ; van Gijn, J | 1 |
Haldemann, R; Lüscher, TF; Szucs, TD | 1 |
Fisher, AA; Le Couteur, DG | 1 |
10 review(s) available for clopidogrel and Brain Hemorrhage, Cerebral
Article | Year |
---|---|
Laboratory Monitoring of Platelet P2Y12 Receptor Inhibitors and Reversal of Antiplatelet Agents.
Topics: Blood Platelets; Carotid Artery Diseases; Cerebral Hemorrhage; Clopidogrel; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Purinergic P2Y Receptor Antagonists | 2019 |
Antiplatelet Therapy in Cerebral Small Vessel Disease.
Topics: Aspirin; Cerebral Hemorrhage; Cerebral Small Vessel Diseases; Clopidogrel; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke | 2019 |
Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysis.
Topics: Adenosine; Aged; Aspirin; Cerebral Hemorrhage; Cerebrovascular Disorders; Clopidogrel; Cohort Studies; Data Interpretation, Statistical; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Piperazines; Platelet Aggregation Inhibitors; Population; Prasugrel Hydrochloride; Randomized Controlled Trials as Topic; Receptors, Purinergic P2; Secondary Prevention; Stroke; Thiophenes; Ticagrelor; Ticlopidine; Vascular Diseases | 2014 |
Intracerebral hemorrhage after pipeline embolization: Management of antiplatelet agents and the case for point-of-care testing--case reports and review of literature.
Topics: Aspirin; Cerebral Hemorrhage; Clinical Protocols; Clopidogrel; Drug Administration Schedule; Embolization, Therapeutic; Humans; Middle Aged; Platelet Aggregation Inhibitors; Platelet Transfusion; Receptors, Purinergic P2Y12; Ticlopidine | 2014 |
Edoxaban versus placebo, aspirin, or aspirin plus clopidogrel for stroke prevention in atrial fibrillation. An indirect comparison analysis.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Drug Synergism; Drug Therapy, Combination; Embolism; Factor Xa Inhibitors; Humans; Mortality; Numbers Needed To Treat; Observational Studies as Topic; Platelet Aggregation Inhibitors; Pyridines; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Stroke; Thiazoles; Thrombophilia; Ticlopidine; Vitamin K | 2015 |
Optimal pediatric dosing of anti-platelet agents for pipeline stent embolization -a case report and review of the literature.
Topics: Adolescent; Aspirin; Bone Neoplasms; Cerebral Hemorrhage; Clopidogrel; Embolization, Therapeutic; Female; Humans; Osteoblastoma; Platelet Aggregation Inhibitors; Ticlopidine | 2017 |
P2X(1) receptor inhibition and soluble CD39 administration as novel approaches to widen the cardiovascular therapeutic window.
Topics: Adenosine Triphosphate; Antigens, CD; Apyrase; Aspirin; Biomedical Research; Cardiovascular Diseases; Cerebral Hemorrhage; Clinical Trials as Topic; Clopidogrel; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Endothelium, Vascular; Humans; Myocardial Ischemia; Platelet Aggregation Inhibitors; Receptors, Purinergic P2; Receptors, Purinergic P2X; Receptors, Purinergic P2Y12; Ticlopidine; Treatment Outcome | 2009 |
Effect of addition of clopidogrel to aspirin on mortality: systematic review of randomized trials.
Topics: Adult; Aged; Aspirin; Cause of Death; Cerebral Hemorrhage; Clopidogrel; Data Interpretation, Statistical; Double-Blind Method; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine; Treatment Outcome | 2012 |
Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas.
Topics: Administration, Oral; Age Factors; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Blood Pressure; Brain Ischemia; Cerebral Hemorrhage; Clinical Trials as Topic; Clopidogrel; Female; Fibrinolytic Agents; Humans; International Normalized Ratio; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Warfarin | 2005 |
[Secondary prevention following cerebral ischemia: is monotherapy with acetylsalicylic acid still first choice?].
Topics: Anticoagulants; Aspirin; Brain Ischemia; Cerebral Hemorrhage; Cerebrovascular Disorders; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Recurrence; Ticlopidine | 1998 |
11 trial(s) available for clopidogrel and Brain Hemorrhage, Cerebral
Article | Year |
---|---|
Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke: The ARAMIS Randomized Clinical Trial.
Topics: Administration, Intravenous; Aged; Aspirin; Cerebral Hemorrhage; Clopidogrel; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Ischemic Stroke; Male; Middle Aged; Platelet Aggregation Inhibitors; Recovery of Function; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome | 2023 |
Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel: Subanalysis of the CSPS.com Trial.
Topics: Aged; Aspirin; Cerebral Hemorrhage; Cilostazol; Clopidogrel; Drug Therapy, Combination; Dual Anti-Platelet Therapy; Female; Humans; Ischemic Stroke; Male; Middle Aged; Platelet Aggregation Inhibitors; Secondary Prevention | 2021 |
Microbleeds in the Secondary Prevention of Small Subcortical Strokes Trial: Stroke, mortality, and treatment interactions.
Topics: Aspirin; Cerebral Hemorrhage; Clopidogrel; Double-Blind Method; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Risk Factors; Secondary Prevention; Stroke, Lacunar; Ticlopidine | 2017 |
Combined clopidogrel-aspirin treatment for high risk TIA or minor stroke does not increase cerebral microbleeds.
Topics: Aged; Aspirin; Cerebral Cortex; Cerebral Hemorrhage; Clopidogrel; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Ticlopidine; Treatment Outcome | 2015 |
Protocol for the comparison of triflusal and clopidogrel in secondary prevention of stroke based on cytochrome P450 2C19 genotyping (MASETRO study): A multicenter, randomized, open-label, parallel-group trial.
Topics: Brain Ischemia; Cerebral Hemorrhage; Chemoprevention; Clopidogrel; Cytochrome P-450 CYP2C19; Follow-Up Studies; Genotype; Humans; Pharmacogenomic Variants; Platelet Aggregation Inhibitors; Recurrence; Salicylates; Secondary Prevention; Single-Blind Method; Stroke; Ticlopidine; Treatment Outcome | 2016 |
Effect of Estimated Glomerular Filtration Rate Decline on the Efficacy and Safety of Clopidogrel With Aspirin in Minor Stroke or Transient Ischemic Attack: CHANCE Substudy (Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events).
Topics: Aged; Aged, 80 and over; Aspirin; Cerebral Hemorrhage; Clopidogrel; Comorbidity; Drug Therapy, Combination; Glomerular Filtration Rate; Humans; Ischemic Attack, Transient; Middle Aged; Outcome Assessment, Health Care; Platelet Aggregation Inhibitors; Renal Insufficiency, Chronic; Severity of Illness Index; Stroke; Ticlopidine | 2016 |
Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score.
Topics: Age Factors; Aged; Aspirin; Body Weight; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Female; Fibrinolytic Agents; Humans; Hypertension; Injections, Intravenous; Logistic Models; Male; Middle Aged; Platelet Aggregation Inhibitors; Predictive Value of Tests; Registries; Risk Factors; Stroke; Ticlopidine; Tissue Plasminogen Activator | 2012 |
Risk of intracerebral hemorrhage in patients with cerebral microbleeds undergoing endovascular intervention.
Topics: Aged; Aged, 80 and over; Aspirin; Atherosclerosis; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Endovascular Procedures; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Stroke; Ticlopidine | 2012 |
Clopidogrel hyper-response and bleeding risk in neurointerventional procedures.
Topics: Adult; Aged; Anticoagulants; Blood Platelets; Cerebral Arteries; Cerebral Hemorrhage; Clopidogrel; Dose-Response Relationship, Drug; Endovascular Procedures; Female; Heparin; Humans; Incidence; Logistic Models; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Risk Factors; Ticlopidine | 2013 |
Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial.
Topics: Aged; Aged, 80 and over; Aspirin; Cerebral Hemorrhage; Clopidogrel; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Ischemic Attack, Transient; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Risk Reduction Behavior; Secondary Prevention; Severity of Illness Index; Simvastatin; Stroke; Ticlopidine; Time Factors; Treatment Outcome | 2007 |
Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W).
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Anticoagulants; Aspirin; Atrial Fibrillation; Biphenyl Compounds; Cerebral Hemorrhage; Clinical Protocols; Clopidogrel; Drug Combinations; Drug Therapy, Combination; Female; Humans; Irbesartan; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Stroke; Tetrazoles; Ticlopidine; Treatment Outcome; Warfarin | 2008 |
43 other study(ies) available for clopidogrel and Brain Hemorrhage, Cerebral
Article | Year |
---|---|
Platelet Function Tests Predicting the Efficacy and Safety of Aspirin Secondary Prevention.
Topics: Aged; Aged, 80 and over; Aspirin; Blood Platelets; Cerebral Hemorrhage; Clopidogrel; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Ischemic Stroke; Male; Middle Aged; Outcome Assessment, Health Care; Platelet Aggregation Inhibitors; Platelet Function Tests; Secondary Prevention | 2022 |
Antiplatelet Medications and Biomarkers of Hemostasis May Explain the Association of Hematoma Appearance and Subsequent Hematoma Expansion After Intracerebral Hemorrhage.
Topics: Aspirin; Biomarkers; Cerebral Hemorrhage; Clopidogrel; Disease Progression; Hematoma; Hemostasis; Humans; Platelet Aggregation Inhibitors | 2022 |
Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: A retrospective nationwide cohort study.
Topics: Aged; Aspirin; Brain Ischemia; Cardiovascular Diseases; Cerebral Hemorrhage; Clopidogrel; Female; Gastrointestinal Hemorrhage; Humans; Male; Propensity Score; Retrospective Studies; Stroke | 2019 |
Dual energy CT in the management of antiplatelet therapy in patients with acute ischemic stroke for carotid obstruction.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Carotid Stenosis; Cerebral Hemorrhage; Clopidogrel; Female; Humans; Ischemic Stroke; Lysine; Magnetic Resonance Angiography; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Thrombectomy; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Trends in Incidence of Intracerebral Hemorrhage and Association With Antithrombotic Drug Use in Denmark, 2005-2018.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Case-Control Studies; Cerebral Hemorrhage; Clopidogrel; Denmark; Female; Fibrinolytic Agents; Humans; Incidence; Logistic Models; Male; Middle Aged; Prevalence; Young Adult | 2021 |
STARTING-SICH Nomogram to Predict Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis for Stroke.
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Nomograms; Risk Factors; Stroke; Thrombolytic Therapy; Ticlopidine; Tissue Plasminogen Activator | 2018 |
Pre-admission use of platelet inhibitors and short-term stroke mortality: a population-based cohort study.
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Denmark; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Patient Admission; Platelet Aggregation Inhibitors; Prognosis; Protective Factors; Registries; Risk Factors; Stroke; Subarachnoid Hemorrhage; Time Factors | 2018 |
Combination Therapy with Dipyridamole and Clopidogrel for Secondary Stroke Prevention in Aspirin-Intolerant Patients After Myocardial Infarction: Results of a Nationwide Case-Control Study.
Topics: Aged; Case-Control Studies; Cerebral Hemorrhage; Clopidogrel; Dipyridamole; Disease-Free Survival; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Myocardial Infarction; Proportional Hazards Models; Secondary Prevention; Stroke; Survival Rate | 2019 |
Cerebral microbleeds in patients with ischemic cerebrovascular disease taking aspirin or clopidogrel.
Topics: Aged; Aspirin; Cerebral Hemorrhage; China; Clopidogrel; Diffusion Magnetic Resonance Imaging; Female; Humans; Leukoencephalopathies; Male; Middle Aged; Myocardial Ischemia; Odds Ratio; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors | 2019 |
Multiple electrode aggregometry in antiplatelet-related intracerebral haemorrhage.
Topics: Adult; Aspirin; Blood Platelets; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Humans; Male; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome | 2013 |
Clopidogrel use is associated with an increased prevalence of cerebral microbleeds in a stroke-free population: the Rotterdam study.
Topics: Aged; Aged, 80 and over; Cerebral Hemorrhage; Clopidogrel; Cross-Sectional Studies; Female; Humans; Male; Microvessels; Middle Aged; Platelet Aggregation Inhibitors; Prevalence; Prospective Studies; Stroke; Ticlopidine | 2013 |
Progressive hemorrhagic transformation following dual antiplatelet therapy.
Topics: Angiography, Digital Subtraction; Aspirin; Brain; Cerebral Angiography; Cerebral Hemorrhage; Clopidogrel; Constriction, Pathologic; Humans; Infarction, Middle Cerebral Artery; Magnetic Resonance Imaging; Male; Middle Aged; Neuroprotective Agents; Stents; Stroke; Thrombectomy; Ticlopidine; Tomography, X-Ray Computed | 2014 |
Variability in initial response to standard clopidogrel therapy, delayed conversion to clopidogrel hyper-response, and associated thromboembolic and hemorrhagic complications in patients undergoing endovascular treatment of unruptured cerebral aneurysms.
Topics: Cerebral Hemorrhage; Clopidogrel; Endovascular Procedures; Female; Humans; Intracranial Aneurysm; Intracranial Embolism; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine | 2014 |
Thrombelastography detects possible coagulation disturbance in patients with intracerebral hemorrhage with hematoma enlargement.
Topics: Aged; Blood Coagulation Disorders; Cerebral Hemorrhage; Clopidogrel; Data Interpretation, Statistical; Female; Hematoma; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Sample Size; Socioeconomic Factors; Thrombelastography; Thrombolytic Therapy; Ticlopidine | 2014 |
Does clopidogrel with aspirin after acute minor stroke or transient ischemic attack increase the risk of cerebral hemorrhage?
Topics: Aspirin; Cerebral Hemorrhage; Clopidogrel; Humans; Ischemic Attack, Transient; Male; Middle Aged; Ticlopidine | 2014 |
How should I treat subacute stent thrombosis in the context of brain haemorrhage with abciximab?
Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Cerebral Hemorrhage; Clopidogrel; Embolic Protection Devices; Female; Humans; Immunoglobulin Fab Fragments; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Stents; Suction; Thrombosis; Ticlopidine | 2015 |
Ventriculostomy-Related Hemorrhage After Treatment of Acutely Ruptured Aneurysms: The Influence of Anticoagulation and Antiplatelet Treatment.
Topics: Acute Disease; Adult; Aged; Aneurysm, Ruptured; Anticoagulants; Aspirin; Cerebral Hemorrhage; Clopidogrel; Endovascular Procedures; Female; Heparin, Low-Molecular-Weight; Humans; Hydrocephalus; Intracranial Aneurysm; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Thromboembolism; Ticlopidine; Tirofiban; Tyrosine; Ventriculostomy | 2015 |
A Novel Use of Direct Platelet Application During Surgery for Clopidogrel-Associated Intracerebral Hemorrhage.
Topics: Aneurysm, False; Aneurysm, Ruptured; Cerebral Angiography; Cerebral Hemorrhage; Clopidogrel; Female; Hemostasis; Humans; Intraoperative Care; Middle Aged; Platelet Aggregation Inhibitors; Platelet Transfusion; Ticlopidine; Treatment Outcome; Vertebral Artery Dissection | 2015 |
Accumetrics-based clopidogrel dosing in endovascular neurosurgery.
Topics: Aged; Aspirin; Cerebral Hemorrhage; Clopidogrel; Drug Therapy, Combination; Endovascular Procedures; Female; Humans; Male; Middle Aged; Neurosurgical Procedures; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Thromboembolism; Ticlopidine; Treatment Outcome | 2015 |
Comparison of antiplatelet regimens in secondary stroke prevention: a nationwide cohort study.
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Cohort Studies; Denmark; Dipyridamole; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Platelet Aggregation Inhibitors; Recurrence; Registries; Secondary Prevention; Stroke; Ticlopidine | 2015 |
Antithrombotic Medication Use and Misuse Among Patients with Intracranial Hemorrhage: A 16-Year, Lebanese, Single-Center Experience.
Topics: Acenocoumarol; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebral Hemorrhage; Clopidogrel; Coronary Artery Disease; Enoxaparin; Female; Fibrinolytic Agents; Humans; Inappropriate Prescribing; Intracranial Hemorrhages; Lebanon; Male; Middle Aged; Platelet Aggregation Inhibitors; Prescription Drug Misuse; Retrospective Studies; Risk Factors; Stroke; Ticlopidine; Warfarin; Young Adult | 2016 |
Risk of bleeding after hospitalization for a serious coronary event: a retrospective cohort study with nested case-control analyses.
Topics: Aged; Aged, 80 and over; Aspirin; Cerebral Hemorrhage; Clopidogrel; Confidence Intervals; Coronary Artery Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Hospitalization; Humans; Incidence; Male; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Survival Rate; Ticlopidine; United Kingdom | 2016 |
Impact of an Interaction Between Clopidogrel and Selective Serotonin Reuptake Inhibitors.
Topics: Aged; Cerebral Hemorrhage; Clopidogrel; Cohort Studies; Cytochrome P-450 CYP2C19 Inhibitors; Databases, Factual; Drug Interactions; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Platelet Aggregation Inhibitors; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Stroke; Ticlopidine | 2017 |
Antiplatelets for stroke prevention: implications of the PRoFESS trial.
Topics: Aspirin; Cerebral Hemorrhage; Clopidogrel; Delayed-Action Preparations; Dipyridamole; Drug Therapy, Combination; Heart Diseases; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Ticlopidine | 2009 |
Platelet activity and outcome after intracerebral hemorrhage.
Topics: Aged; Aged, 80 and over; Aspirin; Blood Platelets; Cerebral Hemorrhage; Clopidogrel; Female; Glasgow Coma Scale; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Severity of Illness Index; Ticlopidine; Treatment Outcome | 2009 |
Reduced platelet activity is more common than reported anti-platelet medication use in patients with intracerebral hemorrhage.
Topics: Aged; Aspirin; Blood Platelets; Cerebral Hemorrhage; Clopidogrel; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Risk Factors; Ticlopidine; Warfarin | 2009 |
Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Recombinant Proteins; Retrospective Studies; Risk Factors; Severity of Illness Index; Thrombolytic Therapy; Thrombophilia; Ticlopidine; Tissue Plasminogen Activator | 2009 |
Reduced platelet activity is associated with more intraventricular hemorrhage.
Topics: Adult; Aged; Aspirin; Blood Platelet Disorders; Blood Platelets; Cerebral Hemorrhage; Clopidogrel; Cohort Studies; Comorbidity; Disease Progression; Female; Humans; Lateral Ventricles; Male; Middle Aged; Outcome Assessment, Health Care; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine | 2009 |
Antiplatelet therapy after coronary intervention in Asia and Japan: the Asian perspective of antiplatelet intervention.
Topics: Asia; Cerebral Hemorrhage; Cerebrovascular Disorders; Cilostazol; Clopidogrel; Coronary Disease; Europe; Humans; Liver; North America; Platelet Aggregation Inhibitors; Pyridines; Tetrazoles; Ticlopidine | 2009 |
Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Contraindications; Dipyridamole; Drug Incompatibility; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Fibrinolytic Agents; Humans; Incidence; Injections, Intravenous; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Assessment; Stroke; Ticlopidine; Tissue Plasminogen Activator; Treatment Outcome; Young Adult | 2010 |
Impact of platelet transfusion on hematoma expansion in patients receiving antiplatelet agents before intracerebral hemorrhage.
Topics: Aged; Aged, 80 and over; Aspirin; Cerebral Hemorrhage; Clopidogrel; Databases, Factual; Female; Hematoma; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Transfusion; Retrospective Studies; Statistics, Nonparametric; Ticlopidine; Treatment Outcome | 2010 |
[Between thrombosis and bleeding - a case of paroxysmal nocturnal hemoglobinuria].
Topics: Aged; Anticoagulants; Aspirin; Cerebral Hemorrhage; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Fatal Outcome; Female; Hemoglobinuria, Paroxysmal; Heparin; Heparin, Low-Molecular-Weight; Humans; Phenprocoumon; Platelet Aggregation Inhibitors; Ticlopidine; Tomography, X-Ray Computed | 2010 |
Delayed intracranial hemorrhage associated with antiplatelet therapy in stent-assisted coil embolized cerebral aneurysms.
Topics: Adult; Aged; Aspirin; Cerebral Hemorrhage; Clopidogrel; Cohort Studies; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Imaging, Three-Dimensional; Intracranial Aneurysm; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Ticlopidine; Tomography Scanners, X-Ray Computed | 2011 |
Antiplatelet pretreatment does not increase hematoma volume in experimental intracerebral hemorrhage.
Topics: Animals; Aspirin; Blood Coagulation; Cerebral Hemorrhage; Clopidogrel; Hematoma; Mice; Plasma Cells; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Failure | 2011 |
Atrial fibrillation, is warfarin the only option for stroke prevention?
Topics: Angiotensin II Type 1 Receptor Blockers; Anticoagulants; Aspirin; Atrial Fibrillation; Biphenyl Compounds; Cerebral Hemorrhage; Clopidogrel; Evidence-Based Medicine; Follow-Up Studies; Humans; Hypertension; Irbesartan; Platelet Aggregation Inhibitors; Stroke; Tetrazoles; Ticlopidine; Treatment Outcome; Warfarin | 2011 |
[Intracerebral hemorrhage in anticoagulated patients: what do we do afterwards?].
Topics: Aged; Anticoagulants; Aspirin; Cerebral Hemorrhage; Clopidogrel; Female; Follow-Up Studies; Humans; Intracranial Embolism; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Retrospective Studies; Risk; Risk Factors; Stroke; Ticlopidine; Vitamin K | 2012 |
Illustration of the impact of antiplatelet drugs on the genesis and management of chronic subdural hematoma.
Topics: Aged; Aged, 80 and over; Aspirin; Cerebral Hemorrhage; Clopidogrel; Drug Therapy, Combination; Hematoma, Subdural, Acute; Hematoma, Subdural, Chronic; Humans; Male; Platelet Aggregation Inhibitors; Postoperative Complications; Remission Induction; Risk Factors; Ticlopidine; Withholding Treatment | 2012 |
Clinical outcomes using a platelet function-guided approach for secondary prevention in patients with ischemic stroke or transient ischemic attack.
Topics: Adenosine Diphosphate; Aged; Arachidonic Acid; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Female; Humans; Ischemic Attack, Transient; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Proportional Hazards Models; Secondary Prevention; Stroke; Survival Analysis; Ticlopidine; Treatment Outcome | 2012 |
Platelet-function testing in patients undergoing neurovascular procedures: caught between a rock and a hard place.
Topics: Cerebral Hemorrhage; Clopidogrel; Drug Resistance; Endovascular Procedures; Female; Humans; Male; Platelet Aggregation Inhibitors; Stents; Thromboembolism; Ticlopidine | 2013 |
Adverse reactions to anticoagulants and to antiplatelet drugs recorded by the German spontaneous reporting system.
Topics: Administration, Oral; Adverse Drug Reaction Reporting Systems; Anticoagulants; Aspirin; Association; Blood Cell Count; Cerebral Hemorrhage; Clopidogrel; Databases, Factual; Drug Information Services; Germany; Hemorrhage; Heparin; Humans; Phenprocoumon; Platelet Aggregation Inhibitors; Product Surveillance, Postmarketing; Thrombocytopenia; Ticlopidine; Time Factors; Treatment Outcome; Vitamin K | 2005 |
Clopidogrel for the prevention of atherothrombotic events.
Topics: Aspirin; Cerebral Hemorrhage; Clopidogrel; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2006 |
[Cost effectiveness of clopidogrel in secondary cardiovascular prevention: a cost-effectiveness analysis based on the Caprie Study].
Topics: Adult; Aged; Arterial Occlusive Diseases; Aspirin; Cerebral Hemorrhage; Cerebral Infarction; Clopidogrel; Cost-Benefit Analysis; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Assessment; Switzerland; Ticlopidine | 2001 |
Intracerebral hemorrhage following possible interaction between celecoxib and clopidogrel.
Topics: Aged; Aged, 80 and over; Celecoxib; Cerebral Hemorrhage; Clopidogrel; Cyclooxygenase Inhibitors; Drug Interactions; Female; Humans; Platelet Aggregation Inhibitors; Pyrazoles; Sulfonamides; Ticlopidine; Tomography, X-Ray Computed | 2001 |